摘要
目的 分析"互联网+"慢性病管理在2型糖尿病患者药物治疗中的作用。方法 选择我院慢病管理门诊于2023年1月-2023年12月内收治的2型糖尿病患者100例,将其随机分为对照组(50例,采取常规慢性病管理方法)和观察组(50例,在对照组的基础上采取"互联网+"慢性病管理方法),对两组患者的临床治疗效果,如患者自我行为管理能力评分、生活质量评分、治疗依从性以及血糖控制情况进行对比和评估。结果 观察组患者的血糖水平指标低于对照组患者,而观察组患者的自我行为管理能力评分和生活质量评分以及治疗依从性均高于对照组患者,差异均有统计学意义(P<0.05)。结论 "互联网+"慢性病管理在2型糖尿病患者药物治疗中取得明显效果,可显著稳定患者的血糖控制情况,提高自我行为管理能力和治疗依从性,改善生活质量,有较高应用价值。
关键词: 互联网+;慢性病管理;2型糖尿病
Abstract
Objective: To analyze the role of "Internet plus" chronic disease management in the drug treatment of type 2 diabetes patients.Methods:100 patients with type 2 diabetes who were admitted to our chronic disease management clinic from January 2023 to December 2023 were randomly divided into the control group (50 patients, using conventional chronic disease management methods) and the observation group (50 patients, using the "Internet plus" chronic disease management method on the basis of the control group). The clinical treatment effects of the two groups of patients, such as patients' self behavior management ability score, quality of life score, treatment compliance and blood sugar control, were compared and evaluated. Results: The blood glucose level indicators of the observation group patients were lower than those of the control group patients, while the self-behavior management ability score, quality of life score, and treatment compliance score of the observation group patients were higher than those of the control group patients, with statistical significance (P<0.05). Conclusion : "Internet plus" chronic disease management has achieved significant results in the drug treatment of type 2 diabetes patients, which can significantly stabilize the blood sugar control of patients, improve self behavior management ability and treatment compliance, and improve the quality of life, with high application value.
Key words: Internet plus; Chronic disease management; Type 2 diabetes
参考文献 References
[1] 刘伟,李晨,龚辉,等.老年2型糖尿病患者药物治疗管理的应用研究进展[J].中国医院用药评价与分析,2024, 24(05): 636-640.
[2] 孙红霞.门诊药学服务干预在2型糖尿病患者中的应用效果探讨[J].基层医学论坛,2024,28(13):7-9+12.
[3] 李继华.达格列净联合常规药物治疗高血压合并2型糖尿病患者的效果[J].中国民康医学,2024,36(08):19-21+25.
[4] Zoi K ,Stella K ,Sofia-Andriani T , et al.Type 2 diabetes mellitus management in patients with chronic kidney disease: an update.[J].Hormones (Athens, Greece), 2020, 19(4):1-10.
[5] Mohammed Z A ,Masoud M .Management of Type 2 Diabetes and Chronic Kidney Disease in Fiji in 2018: Knowledge, Attitude, and Practice of Patients.[J].The review of diabetic studies : RDS,2019,1526-34.
[6] Alberto O ,Roberto A A ,Pablo P E C , et al.Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone.[J].Expert review of clinical pharmacology,2023,16(6):519-531.
[7] 陈莉洁,陈燕琴,罗翠萍.药学服务心理干预对2型糖尿病患者的治疗作用[J].海峡药学,2023,35(05):96-99.
[8] 叶亦香.互联网下延续护理应用于2型糖尿病患者治疗中的临床效果[J].中国医药指南,2023,21(05):19-22.
[9] 王晓曼,解文卿,付静,等.糖尿病患者治疗和病情控制现状及影响因素[J].中国卫生工程学,2023,22(04):503-504+507.